Merck $670 Mil. Charge Anticipates Medicaid Pricing Settlements
Executive Summary
Merck is taking a $670 million pretax charge in 2007 against the anticipated settlement of federal and state investigations of civil claims related to selling practices that include "nominal pricing" and its impact on Medicaid
You may also be interested in...
Merck Marketing, Pricing Practices Lead To Settlement With Justice Dept.
Merck's $650 million settlement with the Department of Justice to resolve state and federal investigations into payment of Medicaid rebates and incentives to health care workers will act as a deterrent to other drug makers, the agency said
Merck Marketing, Pricing Practices Lead To Settlement With Justice Dept.
Merck's $650 million settlement with the Department of Justice to resolve state and federal investigations into payment of Medicaid rebates and incentives to health care workers will act as a deterrent to other drug makers, the agency said
Medicaid AMPs Exclude PBM Discounts Outside Of Mail Order – Final Rules
CMS has been persuaded to exclude pharmacy benefit manager price concessions, other than mail-order, from Medicaid AMPs, because PBMs do not take possession of drug products in most cases nor are their financial transactions easily tracked by manufacturers